Abstract
Despite advances in the treatment and care of severe physical injuries, trauma remains one of the main reasons for disability-adjusted life years worldwide. Trauma patients often suffer from disturbances in energy utilization and metabolic dysfunction, including hyperglycemia and increased insulin resistance. White adipose tissue plays an essential role in the regulation of energy homeostasis and is frequently implicated in traumatic injury due to its ubiquitous body distribution but remains poorly studied. Initial triggers of the trauma response are mainly damage-associated molecular patterns (DAMPs) such as histones. We hypothesized that DAMP-induced adipose tissue inflammation contributes to metabolic dysfunction in trauma patients. Therefore, we investigated whether histone release during traumatic injury affects adipose tissue. Making use of a murine polytrauma model with hemorrhagic shock, we found increased serum levels of histones accompanied by an inflammatory response in white adipose tissue. In vitro, extracellular histones induced an inflammatory response in human adipocytes. On the molecular level, this inflammatory response was mediated via a MYD88-IRAK1-ERK signaling axis as demonstrated by pharmacological and genetic inhibition. Histones also induced lytic cell death executed independently of caspases and RIPK1 activity. Importantly, we detected increased histone levels in the bloodstream of patients after polytrauma. Such patients might benefit from a therapy consisting of activated protein C and the FDA-approved ERK inhibitor trametinib, as this combination effectively prevented histone-mediated effects on both, inflammatory gene activation and cell death in adipocytes. Preventing adipose tissue inflammation and adipocyte death in patients with polytrauma could help minimize posttraumatic metabolic dysfunction.
Similar content being viewed by others
Introduction
Globally, millions of people die from physical injuries every year [1, 2]. Although some decrease in injuries has been observed in the last decades worldwide, trauma remains an important cause of morbidity and mortality in both, developed and developing countries [1]. In 2017, one tenth of the global burden of disease was caused by injuries [2]. Severe tissue trauma can induce a systemic inflammatory response syndrome (SIRS) potentially culminating in organ dysfunction and even failure [3, 4]. The more severe the SIRS, the higher the mortality of trauma patients [5]. In recent years, great efforts have been made to improve the prognosis and outcome of patients with trauma. Nevertheless, trauma consequences remain a medical and societal challenge.
Tissue damage during trauma results in the release of a variety of damage-associated molecular patterns (DAMPs) [3, 6]. These DAMPs include nucleosomes and histones which have been attributed an important role in mediating traumatic SIRS [7, 8]. Histones are basic proteins that bind DNA in the nucleus and play an essential role in chromatin condensation. Outside the cell, however, they can cause considerable harm as injection of histones into mice [9] or release of histones during sepsis [10] resulted in endothelial damage and multiple organ failure. Moreover, increased appearance of extracellular histones is associated with injury severity, acute lung injury, multiorgan failure and mortality in critically injured patients [11]. Circulating free histones and nucleosomes i.e., histones in complex with DNA, were increased and associated with acute lung injury in patients with severe non-thoracic blunt trauma [12]. This fact illustrates that circulating histones even induce damage of remote organs not directly affected by the traumatic impact vector itself.
Trauma patients can suffer from severe metabolic changes such as hyperglycemia and increased insulin resistance [13, 14]. White adipose tissue (WAT) represents the largest organ of the human body and is an essential regulator of energy homeostasis. Furthermore, it functions as an important endocrine organ with crosstalk to e.g., liver, muscle, bone, and brain, thereby controlling vital processes such as food intake, insulin sensitivity, and blood pressure [15, 16]. WAT is found in different parts of the human body: while subcutaneous WAT forms an insulating layer under the skin, visceral WAT coats and secures internal organs. WAT has important mechanical properties and protects parts of the human body exposed to high levels of mechanical stress [16]. Under physiological conditions, WAT stores excess energy as triglycerides. However, little is known about the role of adipose tissue during trauma although almost any traumatic injury causes (co-)damage of WAT. Furthermore, as WAT is strongly supplied with blood, it might even be affected by DAMP release at distant sites.
In this study we utilized a murine model of polytrauma with hemorrhagic shock (PT + HS) and demonstrate increased histone serum levels as well as upregulated inflammatory gene expression in WAT. By performing a detailed in vitro analysis of the response of WAT to extracellular histones in model systems of white adipocytes we provide characterization of the combined impact of histone-induced gene activation and cell death in WAT during trauma on the molecular and functional level. The results presented here may have implications for trauma and critically ill patients suffering from trauma-induced metabolic dysfunction with hyperglycemia and increased insulin resistance.
Materials and methods
Antibodies and reagents
Histones (H9250), cycloheximide (239763) and 7-Cl-O-Nec-1 (504297) were purchased from Sigma-Aldrich (Taufkirchen, Germany), zVAD.fmk from Bachem (Bubendorf, Switzerland), trametinib (GSK1120212) and dinaciclib (S2768) from Selleckchem (Planegg, Germany), TNF (300-01A) from Peprotech (Cranbury, NJ) and Human Activated Protein C (APC) (RP-43095) from Thermo Fisher Scientific (Waltham, MA). The following antibodies were used: cleaved Caspase 3 (#9661, Cell Signaling, Frankfurt am Main, Germany), Caspase-8 (#ALX-804-242-C100, Enzo Life Sciences, Farmingdale, NY), PARP (#9542, Cell Signaling), pIκBα (#9246, Cell Signaling), IκBα (#9242, Cell Signaling), pERK (#9106, Cell Signaling), ERK (#M5670, Sigma-Aldrich), hFAB rhodamine GAPDH (#12004168, BioRad, Hercules, CA), StarBright Blue 520 Goat Anti-Mouse IgG (#12005867), StarBright Blue 700 Goat Anti-Mouse IgG (#12004158), StarBright Blue 520 Goat Anti-Rabbit IgG (#12005870), StarBright Blue 700 Goat Anti-Rabbit IgG (#12004162) (all from BioRad), HRP-labelled goat anti-rabbit Ig (#4010-05, Southern Biotech, Birmingham, AL), HRP-labelled goat anti-mouse IgG2b (#1090-05, Southern Biotech).
Animal experiments
Male C57BL/6 and B6.129S4-Cd14tm1Frm/J mice [17] were obtained from Jackson Laboratories, Bar Harbor, ME, and bred at the animal facility of Oslo University. All animals were genotyped before being transferred to Ulm University Medical Center at least 10 days before starting the experiment. Power analysis was performed before conduction of the study to calculate the appropriate group size. Animals were used at an age of 10-12 weeks. The study protocol was approved by the Federal Authorities for animal research, Tübingen, Germany. All experiments followed the NIH Guidelines for the use of laboratory animals. Animals had free access to food and water.
Mice were randomly assigned to sham treatment (n = 7-8) or polytrauma and hemorrhagic shock (n = 8) as described previously [18, 19]. Anesthesia was initialized with 2.5% sevoflurane (Abbott, Wiesbaden, Germany) in oxygen and sustained during the entire experiment. Briefly, polytrauma consisted of thoracic trauma, closed head injury, and femur fracture including soft tissue injury [20]. Pressure controlled hemorrhage was induced via a microcatheter in the femoral artery and a mean arterial pressure of 30 mmHg (±5 mmHg) was maintained for 60 min. Afterwards, animals were resuscitated with a balanced electrolyte solution and monitored until inguinal and epididymal adipose tissue pads were removed 4 h after trauma. All animals were included in further analyses once they had completed the trauma/sham protocol with the exception of one animal in the treatment group where the availability of inguinal WAT was limited and, which, thus, could not be analyzed by TUNEL assay. Due to the nature of the animal experiment, investigators were not blinded during the animal study protocol. However, investigators were blinded to the group allocation during subsequent experimental procedures.
Histological analysis
Adipose tissue was fixed in 4% formalin, paraffin-embedded, cut into 4 µm sections and stained with hematoxylin and eosin (H&E). Staining of apoptotic cells was performed using the In Situ Cell Death Detection Kit (Roche Diagnostics GmbH, Mannheim, Germany) and nuclei were counterstained with DAPI. Images were taken using an Axio Imager A1 microscope (Zeiss, Oberkochen, Germany). For evaluation of adipocyte apoptosis, the percentage of TUNEL-positive adipocyte nuclei was assessed by a blinded observer in a minimum of six fields of view per animal in 100-fold magnification.
Clinical study
A post-hoc analysis of plasma samples from a monocentered observational study in multiply injured patients and healthy volunteers [21] was performed. Patients were included upon arrival at the emergency department of Ulm University Medical Center if their Injury Severity Score was 25 or higher, and blood was drawn repeatedly during the posttraumatic course.
Nucleosome quantification
Free nucleosomes in human and murine plasma samples were measured using the Cell Death Detection ELISAPLUS (Roche) according to the manufacturer’s instructions and normalized to total plasma protein concentrations. According to the manufacturer the kit quantifies relative amounts of histone-complexed DNA fragments (mono- and oligonucleosomes): “Anti-histone reacts with the histones H1, H2A, H2B, H3 and H4 of various species and anti-DNA binds to single and double-stranded DNA. The ELISA therefore enables the detection of mono- and oligonucleosomes of different species” (https://www.sigmaaldrich.com/DE/en/product/roche/celldethro).
Cell culture
Simpson-Golabi-Behmel syndrome (SGBS) preadipocytes [22,23,24] and human multipotent adipose-derived stem cells (hMADS) [25] were cultured as previously described [24]. Cell lines have not recently been authenticated by STR-profiling or tested for mycoplasma contamination. Differentiation was induced using an adipogenic induction cocktail containing FBS-free DMEM-F12 (Thermo Fisher Scientific) supplemented with 10 μg/ml transferrin, 20 nM insulin, 100 nM cortisol, 200 pM T3, 25 nM dexamethasone, 250 μM IBMX and 2 μM rosiglitazone (all from Sigma-Aldrich) as described [24]. Four days later, medium was changed into FBS-free DMEM-F12 supplemented with 10 μg/ml transferrin, 20 nM insulin, 100 nM cortisol, 200 pM T3. Nalm6 cells were cultured in RPMI supplemented with 20% FBS and 1% L-Glutamine and split twice per week at a ratio of 1:20.
siRNA transfection
For gene knockdown studies, SGBS cells were transfected with 20 nM Dharmacon siGENOME siRNA targeting IRAK1 (M-004760-03-0005) or MYD88 (M-004769-01-0005) or non-targeting control (siGENOME Non-Targeting Control siRNA Pool #2) (all Horizon, Lafayette, CO) mixed with 0.66 μl/cm2 Lipofectamine 2000 or Lipofectamine RNAiMAX (Thermo Fisher Scientific) according to the manufacturer’s protocol.
RNA isolation, reverse transcription and quantitative PCR (qPCR)
Total RNA was isolated with Direct-zol RNA mini Prep Kit (Zymo Research, Freiburg im Breisgau, Germany) according to the manufacturer’s protocol after cells were harvested with Tri-Reagent (Zymo Research). Whole tissues were minced in liquid nitrogen and afterwards resolved in Tri-Reagent. 100 ng to 1 µg RNA were reverse transcribed with SuperScript II Reverse Transcriptase (Thermo Fisher Scientific).
For mRNA quantification the SsoAdvanced Universal SYBR Green Supermix was used on a CFX Connect plate cycler (BioRad) using the primers given below. Results were normalized to the housekeeping gene Hypoxanthin-Guanin-Phosphoribosyltransferase (HPRT) using the 2−ΔCt method [26].
The following murine primer sequences were used (5′ > 3′): Hprt-fwd: GCTGGTGAAAAGGACCTC, Hprt-rev: CACAGGACTAGAACACCT; Il6-fwd: GAT GGA TGC TAC CAA ACT GGA, Il6-rev: TCT GAA GGA CTC TGG CTT TG; Cxcl1-fwd: CTG GGA TTC ACC TCA AGA ACA TC, Cxcl1-rev: CAG GGT CAA GGC AAG CCT C; Tnf-fwd: CCA GAC CCT CAC ACT CAG ATC ATC TTC TC, Tnf-rev: CTA GTT GGT TGT CTT TGA GAT CCA TGC CGT; Mcp1-fwd: AGG TCC CTG TCA TGC TTC TG, Mcp1-rev: GGG ATC ATC TTG CTG GTG AA; Adipoq-fwd: GTT CCT CTT AAT CCT GCC CAG TCA TGC C, Adipoq-rev: GGA CCA AGA AGA CCT GCA TCT CCT TTC TC; Leptin-fwd: GAG ACC CCT GTG TCG GTT C, Leptin-rev: CTG CGT GTG TGA AAT GTC ATT G.
The following human primer sequences were used (5′ > 3′): ADIPOQ-FWD: GGC CGT GAT GGC AGA GAT, ADIPOQ-REV: CTT CAG CCC CGG GTA CT; HPRT-FWD: GAG ATG GGA GGC CAT CAC ATT GTA GCC CTC, HPRT-REV: CTC CAC CAA TTA CTT TTA TGT CCC CTG TTG ACT GGT C; IL6-FWD: TAC CCC CAG GAG AAG ATT CC, IL6-REV: TTT TCT GCC AGT GCC TCT TT; IL8-FWD: TGC CAA GGA GTG CTA AAG AAC TTA GAT GTC AG, IL8-REV: AGC TTT ACA ATA ATT TCT GTG TTG GCG CAG TG; MCP1-FWD: TCC CAA AGA AGC TGT GAT CTT CAA GAC C, MCP1-REV: AGT GAG TGT TCA AGT CTT CGG AGT TTG G; MYD88-FWD: GGC TGC TCT CAA CAT GCG A, MYD88-REV: CTG TGT CCG CA CGT TCA AGA; all from Biomers, Ulm, Germany.
Enzyme-linked immunosorbent assay (ELISA)
Adipokines in SGBS supernatant after histone stimulation were determined using the Human IL-8/CXCL8 DuoSet ELISA and the Human Adiponectin/Acrp30 DuoSet ELISA (both R&D Systems, Abingdon, UK) and the BD OptEIA™ Human IL-6 ELISA Set (BD Biosciences, San Diego, CA) according to manufacturers’ instructions.
Western blot
Protein was harvested and SDS-PAGE and protein transfer were performed as described previously [27]. Images were captured with the ChemidocTM MP (BioRad) imaging system. Uncropped images can be found in the Appendix (Supplementary Information).
TUNEL staining
SGBS cells were seeded on chamber slides (BD Bioscience) and differentiated into adipocytes. On days 10–14, cells were stimulated with 25 or 50 µg/ml histones or left untreated (control) for 16 h prior to staining with the Click-iT™ Plus TUNEL-Assay kit (Thermo Fisher) according to the manufacturer’s instructions. Slides were co-stained with DAPI (Sigma-Aldrich) prior to imaging on the BZ-9000 microscope (Keyence, Osaka, Japan). TUNEL-positive cells were determined using ImageJ Fiji (version 1.54f). TUNEL fluorescence intensity was quantified per nucleus and the percentage of positive nuclei normalized to the respective control.
Propidium iodide staining
25 µg/ml propidium iodide solution (Sigma-Aldrich), 1:1000 diluted BODIPY 493/503 (Thermo Fisher) and 0.5 µM Hoechst33342 (Thermo Fisher) were added to the wells for 10 min after 4 or 24 h of histone stimulation. Microphotographs were taken using the BZ-9000 (Keyence) microscope.
Cell viability assay
The CellTiter-Glo® Luminescent Cell Viability Assay (Promega, Walldorf, Germany) was used according to the manufacturer’s instructions.
Generation of macrophage-conditioned medium
SGBS adipocytes were stimulated with macrophage-conditioned medium as positive control following a previously established protocol [28]. In brief, human THP-1 monocytes were stimulated with 125 ng/ml PMA to differentiate them into macrophages. Conditioned media were collected from 1 million cells/ml incubated in RPMI medium supplemented with 0.1% BSA for 48 h. Adipocytes were treated with 10% macrophage-conditioned medium (Fig. 3F, G).
DNA fragmentation assay
Quantitative determination of DNA fragmentation was performed with SGBS adipocytes [42]. In brief, 4 h after histone stimulation, 100 µl of sixfold concentrated hypotonic fluorochrome solution (250 μg/ml propidium iodide, 1.2% sodium citrate, and 1.2% Triton-X 100) were added to 500 µl stimulation media. After lysis at 4° C for 1 h, cells were resuspended and analyzed by flow cytometry.
Annexin-V/PI staining
SGBS cells on days four to six of adipogenic differentiation were stimulated with 50 µg/ml histones and assessed for Annexin-V/propidium iodide (PI) positivity by flow cytometry. In brief, cells were harvested by trypsinization, centrifuged, washed once with PBS, centrifuged and resuspended in Annexin-V buffer (0.01 M HEPES (Sigma-Aldrich) in Sterofundin) containing Annexin-V-FITC from Roche at a dilution of 1:100. Cells were stained for 25 min at room temperature protected from light. Directly before sample acquisition at the Attune NxT Flow Cytometer PI was added at a final concentration of 1 µg/ml.
Lactate dehydrogenase (LDH) release assay
To quantify LDH release in media supernatant the LDH-Glo™ Cytotoxicity Assay (Promega) was used according to the manufacturer’s protocol.
Statistics
No statistical methods were used to pre-determine sample size for in vitro experiments. In vitro experiments were performed at least three times. GraphPad Prism (version 9.4.1, GraphPad Software, La Jolla, CA) software was used to perform statistical analyses. The statistical tests applied are provided for each figure in the corresponding figure legend.
Results
Polytrauma with hemorrhagic shock induces an inflammatory response in murine WAT
To investigate whether inflammatory changes are detectable in WAT after trauma, we took advantage of a murine polytrauma (PT) model consisting of traumatic brain injury (TBI), thoracic trauma, and fracture/soft tissue injury combined with hemorrhagic shock (HS) [18]. Four hours after trauma induction, the inguinal WAT (iWAT) and gonadal WAT (gWAT) depots were dissected from sites not directly hit by the traumatic force vectors. Here, the overall WAT morphology was not altered in traumatized as compared to sham mice (Fig. 1A, Supplementary Fig. 1A). Next, we assessed whether PT + HS resulted in increased remote adipose tissue inflammation. We found mRNA expression of the inflammatory cytokines TNF (gene: Tnf) and IL-6 (gene: Il6), and of the chemokines (C-X-C motif) ligand (CXCL) 1 (gene: Cxcl1) and MCP-1 (gene: Mcp1) to be significantly increased in iWAT of the trauma group, whereas the classical adipokines adiponectin (gene: Adipoq) and leptin (gene: Lep) were not altered (Fig. 1B). The browning marker uncoupling protein 1 (UCP1; gene: Ucp1) was found to be increased in WAT after surgical trauma [29] yet not altered in iWAT (Fig. 1B). In gWAT, both, inflammatory marker gene expression as well as Adipoq and Lep mRNA expression were not significantly different (Supplementary Fig. 1B).
Although the iWAT depots were not directly hit by the traumatic vector itself they nevertheless showed an inflammatory response upon trauma. Thus, we reasoned that DAMPs might be released from the traumatic sites via the bloodstream thereby affecting iWAT depots. As DAMPs can be sensed by toll-like receptors (TLRs), we next assessed whether TLRs might play a role in mediating the inflammatory response in iWAT depots upon trauma. To interfere with the TLR signaling cascade, we studied the effects of PT + HS in mice carrying a knockout of cluster of differentiation (CD) 14, which is a co-receptor of several TLRs, including TLR2 and TLR4, promoting their intracellular signaling [30,31,32,33,34]. CD14 is expressed by monocytes/macrophages and, to a lesser extent, also by fibroblasts and adipocytes (see The Human Protein Atlas (proteinatlas.org)). The upregulation of Tnf and Mcp1 by PT + HS was completely blunted in iWAT of Cd14−/− mice compared to wild-type (WT) mice (Fig. 1C; data of the Cd14−/− mice was compared to data generated in WT mice shown in detail also in Fig. 1B). Of note, Il6 was significantly higher expressed in iWAT of Cd14−/− mice compared to controls under sham conditions, and the levels further increased with PT + HS (Fig. 1C) suggesting that CD14 is a negative regulator of Il6 expression in iWAT. Lep and Cxcl1 mRNA expression were not affected by absence of CD14 (Supplementary Fig. 1C). In summary, this set of data demonstrates that PT + HS induce a pro-inflammatory response in iWAT mediated, at least in part, by the TLR co-receptor CD14. This suggests TLRs to play a role in trauma-induced adipose tissue inflammation.
DAMPs such as extracellular histones were recently shown to exhibit an important role in trauma-mediated inflammatory signaling and cell death induction [9, 35, 36]. Thus, we measured circulating histones in the form of nucleosomes in our mouse model (Fig. 1D). In line with our hypothesis, circulating histones were increased in WT or Cd14−/− mice with PT + HS as compared to sham-treated mice (Fig. 1D) suggesting that release of histones during trauma could potentially affect distant organs, such as WAT, via the circulation.
Extracellular histones induce an inflammatory response in human white adipocytes
We next investigated whether trauma-induced histone release could directly affect white adipocytes and used human Simpson-Golabi-Behmel syndrome (SGBS) cells as a model system [22,23,24]. These cells show a high adipogenic differentiation capacity and display the typical functional adipocyte features such as insulin-stimulated glucose uptake, beta-adrenergic-stimulated lipolysis, or secretion of adipokines [22,23,24]. SGBS adipocytes were stimulated with increasing histone concentrations ranging from 10–50 µg/ml. This concentration range aligns with concentrations documented in patients following conditions such as blunt chest trauma [12]. The mRNA expression and protein secretion of IL-6 and IL-8 increased in a time- and dose-dependent manner (Fig. 2A, B) while the anti-inflammatory adiponectin was significantly diminished (Fig. 2A, B). The morphology of the cells and the size and number of lipid droplets, however, remained unchanged in the adipocyte cultures upon histone treatment (Fig. 2C). To exclude cell strain-specific effects, we repeated the experiment in adipocytes derived from human multipotent adipose-derived stem (hMADS) cells [25] and observed a similar significant upregulation of the inflammatory markers accompanied by a downregulation of adiponectin (Fig. 2D).
Histone-induced gene activation is mediated via a MYD88-IRAK1-ERK signaling axis
TLRs play an important role in DAMP-induced immune responses in general [37, 38], and in histone-mediated immune responses in particular [39, 40]. In line with our in vivo data, we speculated that extracellular histones may induce inflammatory signaling via activation of TLRs in adipocytes. Therefore, we next modulated the expression of two key mediators of the TLR signaling cascade by RNA interference i.e., myeloid differentiation primary response 88 (MYD88) and interleukin-1 receptor-associated kinase 1 (IRAK1) in SGBS adipocytes. A knockdown of MYD88 on mRNA level by one third (Fig. 3A) was sufficient to significantly block histone-induced IL6 and IL8 mRNA expression (Fig. 3B). Of note, basal expression levels of IL8 mRNA were also significantly downregulated upon knockdown of MYD88 (Fig. 3B), in line with previous reports [41]. In addition, knockdown of IRAK1 (Fig. 3C) significantly prevented upregulation of IL6 and IL8 gene expression upon histone treatment (Fig. 3D) in SGBS adipocytes.
Next, we assessed NF-κB and MAPK signaling activation upon histone stimulation which are both further downstream of MYD88 and IRAK1 in the TLR signaling cascade. Surprisingly, histones did neither induce phosphorylation of IκBα nor its degradation (Fig. 3E). However, we found a robust and sustained phosphorylation of ERK1/2 at Thr202/Tyr204 upon histone exposure (Fig. 3F). In line with this, inhibition of the ERK pathway by trametinib, a reversible, highly selective allosteric FDA-approved inhibitor of the kinases MEK1/2, blocked phosphorylation of ERK1/2 (Fig. 3G) and histone-induced upregulation of IL6 and IL8 (Fig. 3H). Taken together, our data suggests that extracellular histones induce a pro-inflammatory response via a TLR-MYD88-IRAK1-ERK signaling axis in human white adipocytes.
Free histones induce caspase-independent cell death in human white adipocytes
Interestingly, PT + HS resulted in increased TUNEL positivity in iWAT depots in vivo indicative of cell death-associated DNA fragmentation (Fig. 4A). Therefore, we next investigated whether histones also induce cell death in white adipocytes in vitro. Although the cellular morphology remained unaltered (Fig. 2C), we observed an increase in TUNEL-positive nuclei (Fig. 4B) and a loss of cell viability upon stimulation with increasing concentrations of histones in SGBS adipocytes (Fig. 4C). In line with this, the amount of fragmented DNA in sub-G1 [42] concentration-dependently increased (Fig. 4D). Ordered DNA fragmentation is a key feature of apoptosis [43], and extracellular histones are known to induce apoptosis in endothelial cells [44]. Therefore, we assessed molecular key events of apoptosis induction upon histone treatment i.e., cleavage of caspases and PARP. We did not observe cleavage of either Caspase-8 or 3 in SGBS adipocytes upon histone stimulation although these two proteins were robustly cleaved in Nalm6 cells treated with dinaciclib serving as positive control (Fig. 4E). Surprisingly, we did not detect any expression of PARP nor its cleavage in SGBS adipocytes, while the positive control revealed both, PARP expression and cleavage (Fig. 4E). This data is supported by the fact that the loss of cell viability could not be prevented by the pan-caspase inhibitor zVAD.fmk (Fig. 4F). Other forms of caspase-dependent cell death such as pyroptosis consequently could be excluded. Necroptosis is a form of programmed cell death which crucially depends on the activity of receptor interacting protein kinase (RIPK) 1. Inhibition of RIPK1 activity by 7-Cl-O-Nec1 did not prevent the loss of cell viability either alone or in combination with zVAD.fmk (Fig. 4F). Of note, both, zVAD.fmk and 7-Cl-O-Nec1 effectively prevented cell death induced by cycloheximide (CHX) and TNF in SGBS adipocytes (Fig. 4F). Taken together, this set of data suggests that cell death observed in SGBS adipocytes upon histone stimulation is neither executed by caspase-dependent cell death such as apoptosis or pyroptosis nor by RIPK1-dependent necroptosis.
Extracellular histones induce lytic cell death
Histone proteins are positively charged and can bind to negatively charged cell membranes thereby altering phospholipid membrane permeability [36]. This can lead to lytic cell death through a non-programmed cell death mechanism, as seen in e.g. smooth muscle cells [36] or macrophages [45]. To visualize membrane disintegrity, the uptake of propidium iodide (PI) into SGBS adipocytes was analyzed. Here, the number of PI-positive SGBS adipocytes was higher in histone-treated samples compared to controls (Fig. 5A). The PI uptake occurred quickly, and cells did not only stain positive for PI but also for Annexin-V (Fig. 5B), which indicates a rapid loss of membrane integrity upon histone stimulation. Next, we determined the release of lactate dehydrogenase (LDH) into the media supernatant as an additional measure of membrane rupture. Over time, LDH significantly and dose-dependently increased in the supernatant of histone-treated SGBS adipocytes (Fig. 5C).
Activated protein C (APC) is a serum protease known to degrade histones [11]. Thus, we next investigated whether APC could block histone-mediated effects in SGBS adipocytes. Indeed, addition of 100 nM APC significantly reduced histone-induced cell death (Fig. 5D).
APC and trametinib in combination rescue histone-induced cell death and inflammation in adipocytes and might also be advantageous in a clinical setting of trauma
To determine whether APC also prevents histone-induced gene activation we assessed expression of IL6 mRNA upon histone stimulation in presence and absence of APC (Fig. 6A). APC did not block upregulation of IL6 mRNA upon histone exposure suggesting that also fragmented histones exhibit gene activatory capacity. As trametinib was able to prevent gene activation induced by histones (Fig. 3G, H), we next analyzed whether histone-induced cytotoxicity could be prevented by trametinib. This was, however, not the case (Fig. 6B). Thus, we reasoned that the combination of APC and trametinib might be able to prevent both, histone-mediated cytotoxicity and gene activation. Indeed, the combination of both compounds completely blunted histone-induced cell death (Fig. 6C) and inflammation (Fig. 6D).
To assess the clinical significance of histone release, we determined the concentration of free histones in serum of patients suffering from severe trauma (Fig. 6E). The concentration of circulating histones was elevated by ~10-fold in polytrauma patients at the time of admission to the intensive care unit (defined as 0 h) as compared to healthy subjects (Fig. 6E). Already after 4 h, the concentrations significantly dropped again (Fig. 6E) underlining the fact that a potential treatment with APC and trametinib should be initiated as early as possible after the traumatic incident.
Taken together, this data demonstrates that the combination of trametinib and APC prevents the damaging effects of histone release on WAT and might therefore be beneficial in patients with severe injury, who are at risk of developing trauma-induced metabolic dysfunction.
Discussion
In this study, we find that histones are released and detectable in increased amounts in the blood in an animal model of PT + HS and in patients with polytrauma, in line with previous publications [8, 12, 46]. Histones are well-known for their role in tissue injury and inflammation [3, 7]. They are released from dying cells and, when detected extracellularly, generate immunostimulatory and even toxic effects in the surrounding tissue [3, 7]. In parallel to the increase in circulating histones we observed an increase in iWAT inflammation after PT + HS. The gWAT depot showed a similar trend, the results, however, did not reach statistical significance.
Adipocytes and their precursor cells, but also various types of immune cells such as macrophages, dendritic cells, B and T cells reside within WAT [16]. All of these cells can be a source of inflammatory cytokines and chemokines such as TNF, MCP-1, and IL-6 [47]. That adipocytes are a crucial source of inflammatory mediators is highlighted by the fact that adipocyte depletion in mice resulted in a substantial reduction in circulating IL-6 during inflammation [48]. We observed that the trauma-induced inflammatory response in iWAT was at least partially dependent on the presence of the TLR co-receptor CD14 as its absence abolished trauma-induced upregulation of Tnf and Mcp1 in vivo (Fig. 1C). Whether the inflammatory response in vivo originates predominantly from tissue-resident monocytes/macrophages or from the adipocytes and their precursors remains unclear at present. However, we demonstrated that stimulation with histones, an important DAMP released after trauma, elicits a strong inflammatory response in two different human white adipocyte strains in vitro (Fig. 2).
Mechanistically, this inflammatory response was dependent on a MYD88-IRAK1-ERK signaling axis (Fig. 3). Histones can induce inflammation also in other cell types [46, 49], and were identified to mediate their effects via activation of TLRs [12, 39, 40, 46, 49]. We demonstrated that histone-induced upregulation of inflammatory cytokines and chemokines in human white adipocytes is dependent on MYD88 and IRAK1 (Fig. 3A–D), two central signaling adapters in TLR signaling pathways. Histone-mediated inflammation in adipocytes was blocked by use of the FDA-approved MEK-inhibitor trametinib (Fig. 3G, H). Trametinib was identified to abrogate neuroinflammation after traumatic brain injury in mice [50] suggesting that it can ameliorate trauma-induced inflammation in different organs. Interestingly, however, trametinib failed to specifically block histone-induced adipocyte death (Fig. 6B) whereas activated protein C (APC) was very efficient at doing so (Fig. 5D), in line with previous reports [36, 40, 51]. In septic patients a negative correlation was found between plasma histones and endogenous APC, capable of degrading histones [46]. Recombinant APC (Xigris) was the first biologic agent approved for the treatment of severe sepsis and septic shock. The PROWESS trial reported a reduced 28-day mortality [52]. However, these findings could not be replicated in later trials, leading to the withdrawal of Xigris in 2011. In the aftermath, nevertheless, observational studies have consistently shown a Xigris-mediated mortality benefit [53]. However, based on our data, it is tempting to speculate that APC might be useful in patients with trauma to prevent WAT damage, especially in combination with trametinib to also inhibit the histone-mediated inflammatory signaling axis. Future studies might stratify patients for therapeutic APC application based on histone monitoring. Importantly, a therapeutic intervention should be started as early as possible as circulating histones peaked early in patients after polytrauma.
Trauma patients show increased serum levels of certain adipokines such as leptin, IL-17A and IL-33 [54], triglycerides and free fatty acids (FFAs) [55], the latter two being surrogate markers of adipocyte death [56]. Moreover, triglycerides were elevated in the serum of mice after brain injury [57]. This data suggests that WAT damage and adipocyte death may be a more common phenomenon in trauma patients than previously appreciated. Interestingly, the death of adipocytes was independent of caspase activation and RIPK1 activity (Fig. 4E, F). Although adipocytes did not show any overt morphological alterations upon histone treatment (Fig. 2C), we found them to rapidly become PI- and Annexin-V-positive (Fig. 5A, B) after histone stimulation suggesting lytic cell death to occur.
Patients with polytrauma frequently suffer from metabolic changes such as hyperglycemia and insulin resistance. In the context of obesity, insulin resistance develops on grounds of WAT inflammation [58]. We propose that metabolic sequelae of trauma such as insulin resistance, hyperglycemia, glucose intolerance, and high plasma insulin levels could be due to inflammatory processes in WAT. Therefore, preventing adipose tissue inflammation and adipocyte death could help minimizing metabolic dysfunction in patients with polytrauma.
Patients with severe burn injury undergo browning of WAT and present with elevated energy expenditure and a hypermetabolic state [59]. Patsouris et al. proposed that browning after burn injury is mediated via catecholamines [59], which are also responsible for WAT browning upon cold exposure [60]. As adipocyte death was recently suggested to induce the new formation of brown adipose tissue [61] it is possible that also other types of trauma leading to adipocyte death result in WAT browning. In our study, we did, however, not observe any changes in Ucp1 expression of iWAT in vivo as early as 4 h after trauma (Fig. 1B), yet inflammatory genes were already upregulated. At later time points after a focal surgical trauma of WAT, UCP1 expression was induced at both, the trauma site and the contralateral uninjured site [29]. The effect was first visible after 24 h and persisted for at least 5 days [29]. This illustrates a certain temporal sequence of events. At first, DAMP recognition induces inflammation and cell death in adipocytes. Later, adipose tissue remodeling and browning may occur as described by others [29]. Whether there is a direct link between cell death and browning needs to be clarified in future studies. Nevertheless, inhibition of adipocyte death might prevent WAT browning thereby reducing the hypermetabolic state observed in patients with burn injury [59].
Taken together, our study identified extracellular histones as trauma-induced DAMPs leading to inflammation and cell death in WAT. Histones elicit an inflammatory response via activation of a MYD88-IRAK1-ERK signaling axis. In parallel, histone-induced cell death occurs in adipocytes as a non-apoptotic, non-necroptotic form of lytic cell death, which can be inhibited by APC. Inhibition of ERK by trametinib in combination with APC blocked both cell death and inflammation, and might be useful to minimize trauma-induced alterations in white adipose tissue.
Data availability
All data generated or analyzed during this study are included in this published article and its supplementary information files.
References
Haagsma JA, Graetz N, Bolliger I, Naghavi M, Higashi H, Mullany EC, et al. The global burden of injury: incidence, mortality, disability-adjusted life years and time trends from the Global Burden of Disease study 2013. Inj Prev. 2016;22:3–18.
Haagsma JA, James SL, Castle CD, Dingels ZV, Fox JT, Hamilton EB, et al. Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017. Inj Prev. 2020;26 Supp 1:i12–i26.
Vourc’h M, Roquilly A, Asehnoune K. Trauma-induced damage-associated molecular patterns-mediated remote organ injury and immunosuppression in the acutely ill patient. Front Immunol. 2018;9:1330.
Ertel W, Keel M, Marty D, Hoop R, Safret A, Stocker R, et al. Significance of systemic inflammation in 1,278 trauma patients. Unfallchirurg. 1998;101:520–6.
Napolitano LM, Ferrer T, McCarter RJ Jr, Scalea TM. Systemic inflammatory response syndrome score at admission independently predicts mortality and length of stay in trauma patients. J Trauma 2000;49:647–52.
Huber-Lang M, Lambris JD, Ward PA. Innate immune responses to trauma. Nat Immunol. 2018;19:327–41.
Rai V, Mathews G, Agrawal DK. Translational and clinical significance of DAMPs, PAMPs, and PRRs in trauma-induced inflammation. Arch Clin Biomed Res. 2022;6:673–85.
Kanse SM, Gallenmueller A, Zeerleder S, Stephan F, Rannou O, Denk S, et al. Factor VII-activating protease is activated in multiple trauma patients and generates anaphylatoxin C5a. J Immunol. 2012;188:2858–65.
Kawai C, Kotani H, Miyao M, Ishida T, Jemail L, Abiru H, et al. Circulating extracellular histones are clinically relevant mediators of multiple organ injury. Am J Pathol. 2016;186:829–43.
Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, et al. Extracellular histones are major mediators of death in sepsis. Nat Med. 2009;15:1318–21.
Kutcher ME, Xu J, Vilardi RF, Ho C, Esmon CT, Cohen MJ. Extracellular histone release in response to traumatic injury: implications for a compensatory role of activated protein C. J Trauma Acute Care Surg. 2012;73:1389–94.
Abrams ST, Zhang N, Manson J, Liu T, Dart C, Baluwa F, et al. Circulating histones are mediators of trauma-associated lung injury. Am J Respir Crit Care Med. 2013;187:160–9.
Hartl WH, Jauch KW. Metabolic self-destruction in critically ill patients: origins, mechanisms and therapeutic principles. Nutrition. 2014;30:261–7.
Rogobete AF, Grintescu IM, Bratu T, Bedreag OH, Papurica M, Crainiceanu ZP, et al. Assessment of metabolic and nutritional imbalance in mechanically ventilated multiple trauma patients: from molecular to clinical outcomes. Diagnostics. 2019;9:171.
Fasshauer M, Bluher M. Adipokines in health and disease. Trends Pharmacol Sci. 2015;36:461–70.
Rosen ED, Spiegelman BM. What we talk about when we talk about fat. Cell. 2014;156:20–44.
Moore KJ, Andersson LP, Ingalls RR, Monks BG, Li R, Arnaout MA, et al. Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J Immunol. 2000;165:4272–80.
Denk S, Weckbach S, Eisele P, Braun CK, Wiegner R, Ohmann JJ, et al. Role of hemorrhagic shock in experimental polytrauma. Shock. 2018;49:154–63.
Wrba L, Ohmann JJ, Eisele P, Chakraborty S, Braumuller S, Braun CK, et al. Remote intestinal injury early after experimental polytrauma and hemorrhagic shock. Shock. 2019;52:e45–e51.
Weckbach S, Hohmann C, Braumueller S, Denk S, Klohs B, Stahel PF, et al. Inflammatory and apoptotic alterations in serum and injured tissue after experimental polytrauma in mice: distinct early response compared with single trauma or “double-hit” injury. J Trauma Acute Care Surg. 2013;74:489–98.
Halbgebauer R, Halbgebauer S, Oeckl P, Steinacker P, Weihe E, Schafer MK, et al. Neurochemical monitoring of traumatic brain injury by the combined analysis of plasma beta-synuclein, NfL, and GFAP in polytraumatized patients. Int J Mol Sci. 2022;23:9639.
Fischer-Posovszky P, Newell FS, Wabitsch M, Tornqvist HE. Human SGBS cells - a unique tool for studies of human fat cell biology. Obes Facts. 2008;1:184–9.
Tews D, Brenner RE, Siebert R, Debatin KM, Fischer-Posovszky P, Wabitsch M. 20 Years with SGBS cells - a versatile in vitro model of human adipocyte biology. Int J Obes. 2022;46:1939–47.
Wabitsch M, Brenner RE, Melzner I, Braun M, Moller P, Heinze E, et al. Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord. 2001;25:8–15.
Rodriguez AM, Elabd C, Delteil F, Astier J, Vernochet C, Saint-Marc P, et al. Adipocyte differentiation of multipotent cells established from human adipose tissue. Biochem Biophys Res Commun. 2004;315:255–63.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–8.
Wu H, Pula T, Tews D, Amri EZ, Debatin KM, Wabitsch M, et al. microRNA-27a-3p but Not -5p Is a Crucial Mediator of Human Adipogenesis. Cells. 2021;10:3205.
Keuper M, Dzyakanchuk A, Amrein KE, Wabitsch M, Fischer-Posovszky P. THP-1 macrophages and SGBS adipocytes - a new human in vitro model system of inflamed adipose tissue. Front Endocrinol. 2011;2:89.
Longchamp A, Tao M, Bartelt A, Ding K, Lynch L, Hine C, et al. Surgical injury induces local and distant adipose tissue browning. Adipocyte. 2016;5:163–74.
Baumann CL, Aspalter IM, Sharif O, Pichlmair A, Bluml S, Grebien F, et al. CD14 is a coreceptor of Toll-like receptors 7 and 9. J Exp Med. 2010;207:2689–701.
He Z, Riva M, Bjork P, Sward K, Morgelin M, Leanderson T, et al. CD14 Is a co-receptor for TLR4 in the S100A9-induced pro-inflammatory response in monocytes. PLoS ONE. 2016;11:e0156377.
Lee HK, Dunzendorfer S, Soldau K, Tobias PS. Double-stranded RNA-mediated TLR3 activation is enhanced by CD14. Immunity. 2006;24:153–63.
Manukyan M, Triantafilou K, Triantafilou M, Mackie A, Nilsen N, Espevik T, et al. Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1. Eur J Immunol. 2005;35:911–21.
Raby AC, Holst B, Le Bouder E, Diaz C, Ferran E, Conraux L, et al. Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens. Sci Transl Med. 2013;5:185ra64.
Silk E, Zhao H, Weng H, Ma D. The role of extracellular histone in organ injury. Cell Death Dis. 2017;8:e2812.
Silvestre-Roig C, Braster Q, Wichapong K, Lee EY, Teulon JM, Berrebeh N, et al. Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death. Nature. 2019;569:236–40.
Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010;2010:672395.
Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464:104–7.
Huang H, Evankovich J, Yan W, Nace G, Zhang L, Ross M, et al. Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology. 2011;54:999–1008.
Xu J, Zhang X, Monestier M, Esmon NL, Esmon CT. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J Immunol. 2011;187:2626–31.
Morandini AC, Chaves Souza PP, Ramos-Junior ES, Souza Costa CA, Santos CF. MyD88 or TRAM knockdown regulates interleukin (IL)-6, IL-8, and CXCL12 mRNA expression in human gingival and periodontal ligament fibroblasts. J Periodontol. 2013;84:1353–60.
Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991;139:271–9.
Majtnerova P, Rousar T. An overview of apoptosis assays detecting DNA fragmentation. Mol Biol Rep. 2018;45:1469–78.
Ibanez-Cabellos JS, Aguado C, Perez-Cremades D, Garcia-Gimenez JL, Bueno-Beti C, Garcia-Lopez EM, et al. Extracellular histones activate autophagy and apoptosis via mTOR signaling in human endothelial cells. Biochim Biophys Acta Mol Basis Dis. 2018;1864:3234–46.
Zhang Y, Wu C, Li L, Pandeya A, Zhang G, Cui J, et al. Extracellular histones trigger disseminated intravascular coagulation by lytic cell death. Int J Mol Sci. 2022;23:6800.
Ekaney ML, Otto GP, Sossdorf M, Sponholz C, Boehringer M, Loesche W, et al. Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation. Crit Care. 2014;18:543.
Hildebrandt X, Ibrahim M, Peltzer N. Cell death and inflammation during obesity: “Know my methods, WAT(son)”. Cell Death Differ. 2023;30:279–92.
Pajvani UB, Trujillo ME, Combs TP, Iyengar P, Jelicks L, Roth KA, et al. Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy. Nat Med. 2005;11:797–803.
Allam R, Scherbaum CR, Darisipudi MN, Mulay SR, Hagele H, Lichtnekert J, et al. Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol. 2012;23:1375–88.
Huang Y, Li Q, Tian H, Yao X, Bakina O, Zhang H, et al. MEK inhibitor trametinib attenuates neuroinflammation and cognitive deficits following traumatic brain injury in mice. Am J Transl Res. 2020;12:6351–65.
Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS ONE. 2012;7:e32366.
Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709.
Lai PS, Thompson BT. Why activated protein C was not successful in severe sepsis and septic shock: are we still tilting at windmills? Curr Infect Dis Rep. 2013;15:407–12.
Haupt J, Krysiak N, Unger M, Bogner-Flatz V, Biberthaler P, Hanschen M, et al. The potential of adipokines in identifying multiple trauma patients at risk of developing multiple organ dysfunction syndrome. Eur J Med Res. 2021;26:38.
McNamara JJ, Molot M, Dunn R, Burran EL, Stremple JF. Lipid metabolism after trauma. Role in the pathogenesis of fat embolism. J Thorac Cardiovasc Surg. 1972;63:968–72.
Kim SJ, Feng D, Guillot A, Dai S, Liu F, Hwang S, et al. Adipocyte death preferentially induces liver injury and inflammation through the activation of chemokine (C-C Motif) receptor 2-positive macrophages and lipolysis. Hepatology. 2019;69:1965–82.
Kuo JR, Lim SW, Zheng HX, Ho CH, Chang CH, Chio CC, et al. Triglyceride is a good biomarker of increased injury severity on a high fat diet rat after traumatic brain injury. Neurochem Res. 2020;45:1536–50.
Klein S, Gastaldelli A, Yki-Jarvinen H, Scherer PE. Why does obesity cause diabetes? Cell Metab. 2022;34:11–20.
Patsouris D, Qi P, Abdullahi A, Stanojcic M, Chen P, Parousis A, et al. Burn induces browning of the subcutaneous white adipose tissue in mice and humans. Cell Rep. 2015;13:1538–44.
Cypess AM. Reassessing human adipose tissue. N Engl J Med. 2022;386:768–79.
Niemann B, Haufs-Brusberg S, Puetz L, Feickert M, Jaeckstein MY, Hoffmann A, et al. Apoptotic brown adipocytes enhance energy expenditure via extracellular inosine. Nature. 2022;609:361–8.
Acknowledgements
We thank Ez-Zoubir Amri (Université de Nice Sofia-Antipolis, CNRS, Nice, France) for providing hMADS cells. We thank Alexandra Killian and Bettina Berger for their excellent technical assistance, and Dr. Annette Palmer, Sonja Braumueller and Lena Doerfer for their support during the animal study. Furthermore, we thank Prof. Egil Lien (UMass) for providing the WT and Cd14−/− mouse strains. The graphical abstract was created with BioRender.com.
Funding
This work has been supported by the Deutsche Forschungsgemeinschaft as part of the Collaborative Research Center 1149 “Danger Response, Disturbance Factors and Regenerative Potential after Acute Trauma” (A09N, Z02, DFG No. 251293561). JZ is a fellow of the Margarete von Wrangell-Habilitationsprogramm and received funding from Ulm University (Bausteinprogramm). RH received funding from Ulm University (Bausteinprogramm, Hertha-Nathorff-Programm). PFP received funding from the Deutsche Forschungsgemeinschaft (DFG, Heisenberg professorship; project number 497387083). Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Contributions
JR, RH and PF-P conceived the study; JR, JZ, LL, MS, HS, and RH performed research; MH-L, FG, TEM, MW and RH provided material, mice, in vivo samples or data; JR, JZ, MH-L, LL, MS, HS, MAW, US, FG, MW, TEM, KMD, RH and PF-P analyzed and interpreted data; JR, JZ and PF-P co-wrote the manuscript. All authors read and approved the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
The study involving human subjects was approved by the Local Ethics Committee of Ulm University (approval numbers 244/11 and 94/14) and conducted according to the Declaration of Helsinki. Written informed consent was obtained from healthy controls and patients; in case of altered mental status due to sedation, consent was obtained after recovery or from legal representatives.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by Gerry Melino
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Roos, J., Zinngrebe, J., Huber-Lang, M. et al. Trauma-associated extracellular histones mediate inflammation via a MYD88-IRAK1-ERK signaling axis and induce lytic cell death in human adipocytes. Cell Death Dis 15, 285 (2024). https://doi.org/10.1038/s41419-024-06676-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41419-024-06676-9